Sanofi

Big Pharma goes tone deaf

European drug company bosses say the answer to a perceived lack of competitiveness in the EU is to hike medicine prices to US levels

Pfizer Covid vaccines safe and effective for small children, FDA review finds

Sanofi says trials point to potential of its vaccine booster candidate against main variants of concern

Ukrainians in Kilkenny: ‘We are so grateful for all of the help and assistance’

Since the Yevsiutins arrived they have been immersed in the local environs and culture

Irish-founded Wayleadr raises €3.7m to fund global expansion

New York-headquartered company is working to help curb emissions

Poolbeg Pharma signs deal with AI company on influenza data

Project could yield new and better treatments for disease

Nestlé justifies staying in Russia as criticism mounts

Ukrainian government raises pressure on western firms still doing business in Russia

Workday’s Irish arm posts revenues of just under $1bn

Software company employs more than 1,200 in the Republic

FDI works both ways: the two-way street between the US and Ireland

Irish investment into the US is at an all-time high, with over 110,000 US citizens working for Irish companies

European stocks reach fresh highs after gains for bank shares

Markets advance amid expectations of rising interest rates

HealthBeacon raises €6m in investment from Elkstone and Crow Rock

Dublin-headquartered company helps patients better adhere to medication schedules

Dublin market in doldrums as European stocks close down 1%

Pillar banks both down more than 4% in Dublin with CRH and Flutter also lower

Genzyme Ireland sees 50% growth in profits to €65.2m

Numbers employed at the pharma firm last year continued to grow from 714 to 773

European stocks fall 1% on growth worries

Europe-focussed Stoxx 600 on course for its biggest daily decline in three weeks

Sanofi to invest €400m in mRNA vaccines development

French comany is expected to produce a minimum of six clinical candidates by 2025

Kingspan and Kerry shine as European markets advance

Markets await clues on how Fed will handle inflation risk

European shares slip as inflation debate keeps bears on prowl

Signs of rising inflation fan fears of tightening monetary policy

Asia, the ‘factory of the world’, struggles to roll out Covid-19 vaccines

Countries that led the way in controlling virus last year fall behind in global vaccination drive

Covid-19: EU to receive over 1bn vaccines doses by end of September, says document

More than 1bn total doses would be sufficient to immunise entire population of bloc

Malin buys back €4.8m of its own shares

Purchase comes soon after life sciences group’s sale of Kymab stake

Pfizer to start producing Covid-19 vaccine in Ireland by end of the year

Multimillion-euro expansion of Grange Castle plant gets go-ahead with 75 new jobs

GSK moves to make up ground in vaccine race

Company is talking to governments about creating vaccine manufacturing facilities

Novavax plans to ship Covid-19 vaccines to Europe this year

Ireland is in line for up to 2.2m doses of company’s vaccine supply from late-2021

Moderna plans to produce up to 3bn Covid-19 vaccine doses in 2022

Phram company plans to boost output at factories in US, Europe

Malin to return most of $112m Kymab sale funds to investors

ISIF owns almost 11% of Malin, which saw the value of its portfolio jump since late 2019

Johnson & Johnson vaccine Q&A: Is this the game-changer?

Vaccine likely to out-perform rivals with single-dose advantage once rollout accelerates

EU approves single-shot Johnson & Johnson vaccine

Company to deliver 200m doses to EU with 600,000 to Republic between April and June

Covid-19: US will have enough vaccine for every adult by May, says Biden

Texas to drop mask rule as states seek to relax Coronavirus restrictions

Michael Healy-Rae is Dáil’s biggest landlord and declares NYT shares

One-quarter of TDs are property investors or landowners

Why the world’s three biggest vaccine makers failed on Covid-19

Less than a year on, mRNA inoculations look likely to change the industry forever

Malin investors cautious on investment doubling in value

Cantillon: Malin prevented from selling stock for at least 180 days under lock-up agreement

Merkel promises all Germans first vaccine shot by September

Pledge will only be met if pharma companies stick to delivery commitments

EU confirms Pfizer to deliver 75m extra vaccine doses

Additional supply part of deal announced by European Commission president last month

EU faces global criticism over vaccine export restrictions

Canada, Japan and South Korea warn against grab for vaccine supplies

Malin-backed Immunocore files for $100m IPO

Irish investor has 7.4% stake in UK biotech company developing eye cancer therapy

Time for Malin to decide what it wants to be when it grows up

Market Beat: Life sciences company is finally delivering, six years after IPO

Sanofi deal a welcome shot in the arm for Malin investors

Cantillon: Davy says Malin shareholders can expect to see payout of close to €50m based on Monday’s share price

Malin to make up to $145m from sale of Kymab to Sanofi

Irish life sciences company holds 10% stake in immunotherapy firm

EU paying less than US for supplies of Covid vaccine

Trading bloc now accounts for half of all agreed supplies of Pfizer vaccine

Covid-19: 200m doses of Pfizer vaccine to be distributed across EU by September

Newly released timetable confirms bloc will need other vaccines to speed up inoculations

Covid-19: Netherlands to close schools under tough five-week lockdown

World round-up: Eswatini’s prime minister dies after testing positive for coronavirus

Frantic week ends on subdued note as no-deal Brexit looms

Fears over Covid-19 surge and poor prospect of a trade deal weigh on investor sentiment

YOU MAY ALSO LIKE...

Stardust

Inquests into the nightclub fire that led to the deaths of 48 people

Common Ground

How does a post-Brexit world shape the identity and relationship of these islands